{"id":53389,"date":"2023-01-27T19:03:01","date_gmt":"2023-01-27T18:03:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/"},"modified":"2023-01-27T19:03:01","modified_gmt":"2023-01-27T18:03:01","slug":"aer-launches-the-new-review-a-journal-of-practice","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/","title":{"rendered":"AER Launches The New RE:view\u2013A Journal of Practice"},"content":{"rendered":"<div>\n<p>ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;The Association for Education and Rehabilitation of the Blind and Visually Impaired (AER), is excited to announce that the first issue of its new practitioner-focused journal\u2014<i>The New RE:view<\/i>\u2014will be published on January 27. You can read Volume 1, Issue 1 of <i>The New RE:view <\/i>now at <b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmeridian.allenpress.com%2Fthe-new-review&amp;esheet=53292064&amp;newsitemid=20230127005027&amp;lan=en-US&amp;anchor=https%3A%2F%2Fmeridian.allenpress.com%2Fthe-new-review&amp;index=1&amp;md5=7c48ab23b15aec9588c2042a8094f9bb\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/meridian.allenpress.com\/the-new-review<\/a><\/b>.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/4\/AER_Chapter_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg\"><\/a><\/p>\n<p>\nAER is the predominant organization for professionals serving individuals who are blind or have low vision.\n<\/p>\n<p>\n<i>The New RE:view <\/i>(TNR)<i> <\/i>offers a forum for professionals who provide education and rehabilitation services in this specialized field. TNR\u2019s purpose is to share practice-focused insights, personal teaching experiences, and research findings. Through a broad range of full-length articles and shorter pieces, TNR offers new opportunities to share promising instructional techniques, applications, and strategies. The new journal is intended for professionals, people with visual impairments, their families, and anyone who works within the field of visual impairment.\n<\/p>\n<p>\nTNR follows in the footsteps of it<i>s<\/i> predecessor journal, <i>RE:view<\/i>, which was published between 1989 and 2008. In its new incarnation, this peer-reviewed journal becomes a dynamic professional resource addressing key questions that will strengthen AER\u2019s<i> <\/i>community of practice.\n<\/p>\n<p>\nAuthors are encouraged to provide specific information that will permit their work to be applied by other practitioners and researchers. Through a rigorous peer-review process, TNR fulfills its commitment to align practice with theory and research and to assist practitioners in strengthening their services to individuals who are blind or have low vision.\n<\/p>\n<p>\nThe first two issues of TNR will be open access and free to everyone. Subsequent issues will be free to AER members as a benefit to their association membership and available through the AER website. Subscriptions are available through AER for non-members.<b> For information about becoming a member of AER, please visit our website <\/b><b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Faerbvi.org%2Fmembership%2Fapplications-renewal%2F&amp;esheet=53292064&amp;newsitemid=20230127005027&amp;lan=en-US&amp;anchor=https%3A%2F%2Faerbvi.org%2Fmembership%2Fapplications-renewal%2F&amp;index=2&amp;md5=84fb63a776a38bc72e599dd285b4198d\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/aerbvi.org\/membership\/applications-renewal\/<\/a><\/b><b>, or email <\/b><b><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#109;&#x69;&#x63;h&#101;&#108;&#x65;&#x40;ae&#114;&#x62;&#x76;&#x69;&#46;&#111;&#x72;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x69;&#x63;&#x68;&#x65;&#x6c;&#x65;&#64;&#97;&#101;&#114;&#98;vi&#46;o&#x72;&#x67;<\/a><\/b><b>.<\/b>\n<\/p>\n<p>\nTRN accepts manuscripts submitted electronically year-round through the Editorial Manager portal at <b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.editorialmanager.com%2Fthenewreview%2F&amp;esheet=53292064&amp;newsitemid=20230127005027&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.editorialmanager.com%2Fthenewreview%2F&amp;index=3&amp;md5=8a0033f51d2821b86b15909069613d50\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.editorialmanager.com\/thenewreview\/<\/a><\/b>\n<\/p>\n<p>\n<b>Article Genres<\/b>\n<\/p>\n<p>\nTNR\u2019<i>s <\/i>emphasis on applied practice includes a variety of article genres through which authors present their ideas in formats that are useful to readers. TNR accepts manuscripts in five categories: Practice Reflections, Practice Reports, Applied Research Reports, Book Reviews, and Views from the Field,\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Association for Education and Rehabilitation of the Blind and Visually Impaired (AER)<\/b><br \/>Lee Sonnenberg, Executive Director<br \/>\n<br \/>703-671-4500<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6c;e&#x65;&#64;&#x61;e&#x72;b&#118;&#x69;&#46;&#x6f;&#114;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6c;&#x65;&#101;&#64;&#x61;&#x65;&#x72;&#98;v&#x69;&#x2e;&#x6f;&#114;g<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;The Association for Education and Rehabilitation of the Blind and Visually Impaired (AER), is excited to announce that the first issue of its new practitioner-focused journal\u2014The New RE:view\u2014will be published on January 27. You can read Volume 1, Issue 1 of The New RE:view now at https:\/\/meridian.allenpress.com\/the-new-review. AER is the predominant organization for &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53389","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AER Launches The New RE:view\u2013A Journal of Practice - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AER Launches The New RE:view\u2013A Journal of Practice - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;The Association for Education and Rehabilitation of the Blind and Visually Impaired (AER), is excited to announce that the first issue of its new practitioner-focused journal\u2014The New RE:view\u2014will be published on January 27. You can read Volume 1, Issue 1 of The New RE:view now at https:\/\/meridian.allenpress.com\/the-new-review. AER is the predominant organization for ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-27T18:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"AER Launches The New RE:view\u2013A Journal of Practice\",\"datePublished\":\"2023-01-27T18:03:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/\"},\"wordCount\":404,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230127005027\\\/en\\\/1697555\\\/21\\\/AER_Chapter_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/\",\"name\":\"AER Launches The New RE:view\u2013A Journal of Practice - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230127005027\\\/en\\\/1697555\\\/21\\\/AER_Chapter_Logo.jpg\",\"datePublished\":\"2023-01-27T18:03:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230127005027\\\/en\\\/1697555\\\/21\\\/AER_Chapter_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230127005027\\\/en\\\/1697555\\\/21\\\/AER_Chapter_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aer-launches-the-new-review-a-journal-of-practice\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AER Launches The New RE:view\u2013A Journal of Practice\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AER Launches The New RE:view\u2013A Journal of Practice - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/","og_locale":"en_US","og_type":"article","og_title":"AER Launches The New RE:view\u2013A Journal of Practice - Pharma Trend","og_description":"ALEXANDRIA, Va.&#8211;(BUSINESS WIRE)&#8211;The Association for Education and Rehabilitation of the Blind and Visually Impaired (AER), is excited to announce that the first issue of its new practitioner-focused journal\u2014The New RE:view\u2014will be published on January 27. You can read Volume 1, Issue 1 of The New RE:view now at https:\/\/meridian.allenpress.com\/the-new-review. AER is the predominant organization for ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-27T18:03:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"AER Launches The New RE:view\u2013A Journal of Practice","datePublished":"2023-01-27T18:03:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/"},"wordCount":404,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/","url":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/","name":"AER Launches The New RE:view\u2013A Journal of Practice - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg","datePublished":"2023-01-27T18:03:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230127005027\/en\/1697555\/21\/AER_Chapter_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aer-launches-the-new-review-a-journal-of-practice\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"AER Launches The New RE:view\u2013A Journal of Practice"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53389"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53389\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}